1Lebrethon M C, Bourguignon J P. Management of central isosexual precocity: diagnosis, treatment, outcome[J]. Curr Opin Pediatr,2000,12(4):394-399.
2Antoniazzi F, Zamboni G. Central precocious puberty: current treatment options[J]. Paediatr Drugs,2004,6(4):211-231.
3Muller J, Juul A, Andersson A M, et al. Hormonal changes during GnRH analogue therapy in children with central precocious puberty[J]. J Pediatr Endocrinol Metab,2000,13(Suppl 1):739-746.
4Antoniazzi F, Zamboni G, Bertoldo F, Bone development during GH and GnRH analog treatment[J]. Eur J Endocrinol,2004,151(Suppl 2):S47-S54.
5Weise M, Flor A, Barnes K M. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty[J]. J Clin Endocrinol Metab,2004,89(1):103-107.
6Rose S R, Schreiber R E, Kearney N S. Hypothalamic dysfunction afterchemotherapy[J]. J Pediatr Endocrinol Metab,2004,17(1):55-66.
7Wit J M, Balen H V, Kamp G A. Benefit of postponing normal puberty for improving final height[J]. Eur J Endocrinol,2004,151(Suppl 1):S41-S45.
8Lee P A. The effects of manipulation of puberty on growth[J]. Horm Res,2003,60(Suppl 1):S60-S67.
9Tuvemo T, Jonsson B, Gustafsson J. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty[J]. Acta Paediatr,2004,93(11):1456-1462.
10Huguenin M, Trivin C, Zerah M, et al. Adult height after cranial irradiation for optic pathway tumors: relationship with neurofibromatosis[J]. J Pediatr,2003,142(6):699-703.
